Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide

Direct Gene Transfer into Mouse Muscle in Vivo

Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · cited 1× · see citing works

mRNA-based therapeutics--developing a new class of drugs

Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works

Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues

Lai, S. K., Wang, Y.-Y., & Hanes, J. S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,827 · see citing works

Polyethylene glycol (PEG): A versatile polymer for pharmaceutical applications

D’souza, A. A., & Shegokar, R. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1182485 · Cited by 1,282 · see citing works

Expression of therapeutic proteins after delivery of chemically modified mRNA in mice

Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733 · see citing works

Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses

Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.035 · Cited by 642 · see citing works

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells

Holtkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., Türeci, O., & Sahin, U. (2006) · Blood · doi:10.1182/blood-2006-04-015024 · Cited by 625 · see citing works

PEGylation for enhancing nanoparticle diffusion in mucus

Huckaby, J. T., & Lai, S. K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.08.010 · Cited by 467 · see citing works

Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems

Guan, S., & Rosenecker, J. (2017) · Gene Therapy · doi:10.1038/gt.2017.5 · Cited by 389 · see citing works

Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium

Patel, A. K., Kaczmarek, J. C., Bose, S., Kauffman, K. J., Mir, F. F., Heartlein, M. W., DeRosa, F., Langer, R., & Anderson, D. G. (2019) · Advanced Materials · doi:10.1002/adma.201805116 · Cited by 383 · see citing works

Protein Inhalation Powders: Spray Drying vs Spray Freeze Drying

Maa, Y., Nguyen, P., Sweeney, T. D., Shire, S. J., & Hsu, C. C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018828425184 · Cited by 356 · see citing works

Reversal of Diabetes Insipidus in Brattleboro Rats: Intrahypothalamic Injection of Vasopressin mRNA

Jirikowski, G. F., Sanna, P. P., Maciejewski-Lenoir, D., & Bloom, F. E. (1992) · Science · doi:10.1126/science.1546298 · Cited by 282 · see citing works

Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis

Robinson, E., MacDonald, K. D., Slaughter, K., McKinney, M., Patel, S., Sun, C., & Sahay, G. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.014 · Cited by 272 · see citing works

mRNA as gene therapeutic: How to control protein expression

Tavernier, G., Andries, O., Demeester, J., Sanders, N. N., De Smedt, S. C., & Rejman, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.020 · Cited by 232 · see citing works

Extracellular barriers in respiratory gene therapy

Sanders, N. N., Rudolph, C., Braeckmans, K., Smedt, S. C. D., & Demeester, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.011 · Cited by 229 · see citing works

PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy

Osman, G., Rodriguez, J., Chan, S. Y., Chisholm, J., Duncan, G. A., Kim, N., Tatler, A. L., Shakesheff, K. M., Hanes, J. S., Suk, J. S., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.001 · Cited by 207 · see citing works

Dry powder formulations for pulmonary delivery

Malcolmson, R., & Embleton, J. K. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00099-6 · Cited by 177 · see citing works

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

Sebastian, M., Papachristofilou, A., Weiß, C., Früh, M., Cathomas, R. L., Hilbe, W., Wehler, T., Rippin, G., Koch, S. D., Scheel, B., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-748 · Cited by 142 · see citing works

Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism

Mays, L. E., Ammon-Treiber, S., Mothes, B., Alkhaled, M., Rottenberger, J., Müller-Hermelink, E. S., Grimm, M., Mezger, M., Beer-Hammer, S., von Stebut, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65351 · Cited by 113 · see citing works

Dry Powder Aerosol Delivery Systems: Current and Future Research Directions

Chan, H. (2006) · Journal of Aerosol Medicine · doi:10.1089/jam.2006.19.21 · Cited by 107 · see citing works

Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases

Sahu, I., Haque, A. K. M. A., Weidensee, B., Weinmann, P., & Kormann, M. S. D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.019 · Cited by 104 · see citing works

Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity

Uchida, S., Kataoka, K., & Itaka, K. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7030137 · Cited by 88 · see citing works

Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis

Haque, A. K. M. A., Dewerth, A., Antony, J. S., Riethmüller, J., Schweizer, G. R., Weinmann, P., Latifi, N., Yasar, H., Pedemonte, N., Sondo, E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34960-0 · Cited by 80 · see citing works

Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity

Okuda, T., Morishita, M., Mizutani, K., Shibayama, A., Okazaki, M., & Okamoto, H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.003 · Cited by 74 · see citing works

Particle Size Analysis of Aerosols from Medicinal Inhalers

Mitchell, J. P., & NAGEL, M. W. (2004) · KONA Powder and Particle Journal · doi:10.14356/kona.2004010 · Cited by 73 · see citing works

SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency

Connolly, B., Isaacs, C., Cheng, L., Asrani, K. H., & Subramanian, R. R. (2018) · Journal of Nucleic Acids · doi:10.1155/2018/8247935 · Cited by 67 · see citing works

Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer

Chow, M. Y. T., Qiu, Y., Lo, F. F. K., Lin, H. H. S., Chan, H., Kwok, P. C. L., & Lam, J. K. W. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.013 · Cited by 66 · see citing works

Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition

Liao, Q., Yip, L., Chow, M. Y. T., Chow, S. F., Chan, H., Kwok, P. C. L., & Lam, J. K. W. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.057 · Cited by 60 · see citing works

Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation

Liang, W., Chow, M. Y. T., Chow, S. F., Chan, H., Kwok, P. C. L., & Lam, J. K. W. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.045 · Cited by 56 · see citing works

Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray drying

Agnoletti, M., Bohr, A., Thanki, K., Wan, F., Zeng, X., Boetker, J. P., Yang, M., & Foged, C. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.08.001 · Cited by 53 · see citing works

Receptor-Interacting Protein 2 Gene Silencing Attenuates Allergic Airway Inflammation

Goh, F. Y., Cook, K. L. T. P., Upton, N. E. G., Tao, L., Lah, L. C., Leung, B. P. L., & Wong, W. S. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202416 · Cited by 50 · see citing works

From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery

Qiu, Y., Chow, M. Y. T., Liang, W., Chung, W. W. Y., Mak, J., & Lam, J. K. W. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00725 · Cited by 50 · see citing works

Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders

Wu, J., Wu, L., Wan, F., Rantanen, J., Cun, D., & Yang, M. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.019 · Cited by 47 · see citing works

Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration

Johler, S. M., Rejman, J., Guan, S., & Rosenecker, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137504 · Cited by 46 · see citing works

Challenges Associated with the Pulmonary Delivery of Therapeutic Dry Powders for Preclinical Testing

Price, D. N., Kunda, N. K., & Muttil, P. (2018) · KONA Powder and Particle Journal · doi:10.14356/kona.2019008 · Cited by 44 · see citing works

Small interfering RNA against CD86 during allergen challenge blocks experimental allergic asthma

Asai, Y., Matsumoto, K., Fukuyama, S., Kan‐o, K., Nakano, T., Tonai, K., Ohno, T., Azuma, M., Inoue, H., & Nakanishi, Y. (2014) · Respiratory Research · doi:10.1186/s12931-014-0132-z · Cited by 39 · see citing works

Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design

Farkas, D. R., Hindle, M., & Longest, P. W. (2015) · Annals of Biomedical Engineering · doi:10.1007/s10439-015-1335-2 · Cited by 35 · see citing works

Dry Powder Formulation of Plasmid DNA and siRNA for Inhalation

Chow, M., & Lam, J. K. W. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150820105916 · Cited by 34 · see citing works

Intratracheal Administration of siRNA Dry Powder Targeting Vascular Endothelial Growth Factor Inhibits Lung Tumor Growth in Mice

Miwata, K., Okamoto, H., Nakashima, T., Ihara, D., Horimasu, Y., Masuda, T., Miyamoto, S., Iwamoto, H., Fujitaka, K., Hamada, H., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.07.009 · Cited by 33 · see citing works

Monodisperse engineered PEGs for bio-related applications

Kinbara, K. (2018) · Polymer Journal · doi:10.1038/s41428-018-0074-2 · Cited by 27 · see citing works

Establishment of an Evaluation Method for Gene Silencing by Serial Pulmonary Administration of siRNA and pDNA Powders: Naked siRNA Inhalation Powder Suppresses Luciferase Gene Expression in the Lung

Ito, T., Okuda, T., Takayama, R., & Okamoto, H. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.03.029 · Cited by 27 · see citing works

mRNA-based therapeutics: powerful and versatile tools to combat diseases

Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 801 · see citing works

mRNA vaccine: a potential therapeutic strategy

Wang, Y., Zhang, Z., Luo, J., Han, X., Wei, Y., & Wei, X. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01311-z · Cited by 422 · see citing works

COVID-19 mRNA vaccines: Platforms and current developments

Szabó, G. T., Mahiny, A. J., & Vlatkovic, I. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.02.016 · Cited by 308 · see citing works

Formulation and Delivery Technologies for mRNA Vaccines

Zeng, C., Zhang, C., Walker, P. G., & Dong, Y. (2020) · Current topics in microbiology and immunology · doi:10.1007/82_2020_217 · Cited by 221 · see citing works

Delivery Strategies for mRNA Vaccines

Ramachandran, S., Satapathy, S. R., & Dutta, T. (2022) · Pharmaceutical Medicine · doi:10.1007/s40290-021-00417-5 · Cited by 182 · see citing works

Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments

Zhang, H., Leal, J., Soto, M. R., Smyth, H. D. C., & Ghosh, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111042 · Cited by 159 · see citing works

Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung

Rotolo, L., Vanover, D. A., Bruno, N. C., Peck, H. E., Zurla, C., Murray, J., Noel, R. K., O’Farrell, L., Araínga, M., Orr‐Burks, N., et al. (2022) · Nature Materials · doi:10.1038/s41563-022-01404-0 · Cited by 157 · see citing works

Strategies for non-viral vectors targeting organs beyond the liver

Kim, J., Eygeris, Y., Ryals, R. C., Jozić, A., & Sahay, G. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01563-4 · Cited by 154 · see citing works

Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2

Ai, L., Li, Y., Zhou, L., Yao, W., Zhang, H., Hu, Z., Han, J., Wang, W., Wu, J., Xu, P., et al. (2023) · Cell Discovery · doi:10.1038/s41421-022-00517-9 · Cited by 148 · see citing works

Nanoparticle-Based Drug Delivery System: The Magic Bullet for the Treatment of Chronic Pulmonary Diseases

Pramanik, S., Mohanto, S., Manne, R., Rajendran, R. R., Deepak, A., Edapully, S. J., Patil, T., & Katari, O. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00491 · Cited by 143 · see citing works

Nanoplatforms for mRNA Therapeutics

Meng, C., Chen, Z., Li, G., Welte, T., & Shen, H. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000099 · Cited by 130 · see citing works

The nano delivery systems and applications of mRNA

Li, M., Li, Y., Li, S., Jia, L., Wang, H., Li, M., Deng, J., Zhu, A., Ma, L., Li, W., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113910 · Cited by 124 · see citing works

From structural design to delivery: mRNA therapeutics for cancer immunotherapy

Zhou, F., Huang, L., Li, S., Yang, W., Chen, F., Cai, Z., Liu, X., Xu, W., Lehto, V., Lächelt, U., et al. (2023) · Exploration · doi:10.1002/exp.20210146 · Cited by 115 · see citing works

mRNA vaccines for COVID-19 and diverse diseases

Hussain, A., Yang, H., Zhang, M., Liu, Q., Alotaibi, G., Irfan, M. F., He, H., Chang, J. K., Liang, X., Weng, Y., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.032 · Cited by 117 · see citing works

Inhaled RNA Therapy: From Promise to Reality

Chow, M. Y. T., Qiu, Y., & Lam, J. K. W. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.08.002 · Cited by 105 · see citing works

Dry powder pharmaceutical biologics for inhalation therapy

Chang, R. Y. K., Chow, M. Y. T., Khanal, D., Chen, D., & Chan, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.017 · Cited by 106 · see citing works

mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients

Bidram, M., Zhao, Y., Shebardina, N. G., Baldin, A. V., Bazhin, A. V., Ganjalikhany, M. R., Zamyatnin, A. A., & Ganjalıkhani-Hakemi, M. (2021) · Vaccines · doi:10.3390/vaccines9101060 · Cited by 106 · see citing works

Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy

Jin, Z., Gao, Q., Wu, K., Ouyang, J., Guo, W., & Liang, X. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115111 · Cited by 99 · see citing works

Mucosal vaccine delivery: A focus on the breakthrough of specific barriers

Huang, M., Zhang, M., Zhu, H., Du, X., & Wang, J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.07.002 · Cited by 96 · see citing works

Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19

Heida, R., Hinrichs, W. L. J., & Frijlink, H. W. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1903878 · Cited by 92 · see citing works

Engineering nanoparticle toolkits for mRNA delivery

Sun, B. F., Wu, W., Narasipura, E. A., Ma, Y., Yu, C., Fenton, O. S., & Song, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115042 · Cited by 93 · see citing works

Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery

Boisguérin, P., Konate, K., Josse, E., Vivès, É., & Deshayes, S. (2021) · Biomedicines · doi:10.3390/biomedicines9050583 · Cited by 88 · see citing works

Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery

Wang, H., Lu, Q., Zhang, X., Guan, J., & Mao, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.061 · Cited by 88 · see citing works

Cell-Penetrating Peptides: Emerging Tools for mRNA Delivery

Yokoo, H., Oba, M., & Uchida, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010078 · Cited by 86 · see citing works

Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications

Lopes, C., Cristóvão, J. S., Silvério, V., Lino, P. R., & Fonte, P. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2135502 · Cited by 85 · see citing works

Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research

Chan, H. W., Chow, S., Zhang, X., Zhao, Y., Tong, H. H. Y., & Chow, S. F. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02559-y · Cited by 85 · see citing works

Emerging delivery approaches for targeted pulmonary fibrosis treatment

Diwan, R., Bhatt, H., Beaven, E., & Nurunnabi, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115147 · Cited by 78 · see citing works

Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA

Friis, K. P., Gracin, S., Oag, S., Leijon, A., Sand, E., Lindberg, B., Lázaro‐Ibáñez, E., Lindqvist, J., Whitehead, K. A., & Bak, A. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.031 · Cited by 76 · see citing works

Advances in Nanoparticles for Effective Delivery of RNA Therapeutics

Byun, M. J., Lim, J., Kim, S.-N., Park, D.-H., Kim, T. P., Park, W., & Park, C. G. (2022) · BioChip Journal · doi:10.1007/s13206-022-00052-5 · Cited by 76 · see citing works

A Review of Non-Invasive Drug Delivery through Respiratory Routes

Zhang, Y., Xu, D. W., Bai, L., Zhou, Y.-M., Zhang, H., & Cui, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091974 · Cited by 77 · see citing works

The Delivery of mRNA Vaccines for Therapeutics

Nitika, Wei, J., & Hui, A. (2022) · Life · doi:10.3390/life12081254 · Cited by 70 · see citing works

Engineering the right formulation for enhanced drug delivery

Ke, W.-R., Chang, R. Y. K., & Chan, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114561 · Cited by 67 · see citing works

Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA

Miao, H., Huang, K., Li, Y., Li, R., Zhou, X., Shi, J., Tong, Z., Sun, Z., & Yu, A. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123050 · Cited by 64 · see citing works

Get out or die trying: Peptide- and protein-based endosomal escape of RNA therapeutics

Klipp, A., Burger, M., & Leroux, J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115047 · Cited by 63 · see citing works

Recent Advances in the Noninvasive Delivery of mRNA

Qin, M., Du, G., & Sun, X. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00493 · Cited by 60 · see citing works

Inhalable dry powder product (DPP) of mRNA lipid nanoparticles (LNPs) for pulmonary delivery

Sarode, A., Patel, P., Vargas‐Montoya, N., Allawzi, A. M., Zhilin-Roth, A., Karmakar, S., Boeglin, L., Deng, H., Karve, S., & DeRosa, F. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01402-y · Cited by 64 · see citing works

Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy

Wang, Y., Zhang, R., Tang, L., & Li, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030512 · Cited by 57 · see citing works

Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery

Farinha, S., Sá, J. V., Lino, P. R., Galésio, M., Pires, J., Rodrigues, M. Â., & Henriques, J. G. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03442-4 · Cited by 57 · see citing works

Advances of mRNA vaccine in tumor: a maze of opportunities and challenges

Yuan, Y., Gao, F., Chang, Y., Zhao, Q., & He, X. (2023) · Biomarker Research · doi:10.1186/s40364-023-00449-w · Cited by 58 · see citing works

Next-Generation COVID-19 Vaccines Should Take Efficiency of Distribution into Consideration

AboulFotouh, K., Cui, Z., & Williams, R. O. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-01974-3 · Cited by 56 · see citing works

Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa

Tang, J., Cai, L., Xu, C., Sun, S., Liu, Y., Rosenecker, J., & Guan, S. (2022) · Nanomaterials · doi:10.3390/nano12020226 · Cited by 54 · see citing works

Cancer-related micropeptides encoded by ncRNAs: Promising drug targets and prognostic biomarkers

Setrerrahmane, S., Li, M., Zoghbi, A., Lv, X., Zhang, S., Zhao, W., Lu, J., Craik, D. J., & Xu, H. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215723 · Cited by 58 · see citing works

Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol

Neary, M. T., Mulder, L. M., Kowalski, P. S., MacLoughlin, R. J., Crean, A. M., & Ryan, K. B. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.012 · Cited by 62 · see citing works

Inhalation delivery technology for genome-editing of respiratory diseases

Chow, M. Y. T., Chang, R. Y. K., & Chan, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.001 · Cited by 54 · see citing works

Targeting strategies for mRNA delivery

Meyer, R. A., Neshat, S. Y., Green, J. J., Santos, J. L., & Tuesca, A. D. (2022) · Materials Today Advances · doi:10.1016/j.mtadv.2022.100240 · Cited by 53 · see citing works

Emerging Concepts of Nanobiotechnology in mRNA Delivery

Wang, Y., & Yu, C. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202003545 · Cited by 52 · see citing works

Recent advances in drying and development of solid formulations for stable mRNA and siRNA lipid nanoparticles

Arte, K. S., Chen, M., Patil, C. D., Huang, Y., Qu, L. L., & Zhou, Q. T. (2024) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2024.12.013 · Cited by 51 · see citing works

Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing

Kim, D., Le, Q., Wu, Y., Park, J.-W., & Oh, Y. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121233 · Cited by 50 · see citing works

Novel formulations and drug delivery systems to administer biological solids

Zhang, Y., Davis, D. A., AboulFotouh, K., Wang, J., Williams, D., Bhambhani, A., Zakrewsky, M., Maniruzzaman, M., Cui, Z., & Williams, R. O. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.011 · Cited by 47 · see citing works

Dynamic mRNA polyplexes benefit from bioreducible cleavage sites for in vitro and in vivo transfer

Levačić, A. K., Berger, S., Müller, J., Wegner, A., Lächelt, U., Dohmen, C., Rudolph, C., & Wagner, E. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.016 · Cited by 47 · see citing works

Polyplex designs for improving the stability and safety of RNA therapeutics

Uchida, S., Lau, C. Y. J., Oba, M., & Miyata, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114972 · Cited by 46 · see citing works

Nanoparticles for local delivery of siRNA in lung therapy

Kubczak, M., Michlewska, S., Bryszewska, M. J., Aigner, A. M., & Йонов, М. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114038 · Cited by 47 · see citing works

Engineered mRNA Delivery Systems for Biomedical Applications

Wang, J., Zhu, H., Gan, J., Liang, G., Li, L., & Zhao, Y. (2023) · Advanced Materials · doi:10.1002/adma.202308029 · Cited by 44 · see citing works

Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives

Zhang, Y., Liu, C., Wu, C., & Song, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114257 · Cited by 43 · see citing works

Surfactant Protein B Promotes Cytosolic SiRNA Delivery by Adopting a Virus-like Mechanism of Action

Guagliardo, R., Herman, L., Penders, J., Zamborlin, A., Keersmaecker, H. D., de Vyver, T. V., Verstraeten, S. L., Merckx, P., Mingeot‐Leclercq, M., Echaide, M., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c04489 · Cited by 42 · see citing works

mRNA delivery enabled by metal–organic nanoparticles

Gu, Y., Chen, J., Wang, Z., Liu, C., Wang, T., Kim, C., Ďuríková, H., Fernandes, S., Johnson, D. N., Rose, R. D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53969-w · Cited by 41 · see citing works

Delivery of synthetic mRNAs for tissue regeneration

Steinle, H., Weber, M., Stoppelkamp, S., Große‐Berkenbusch, K., Golombek, S., Weber, M., Çanak-Ipek, T., Trenz, S.-M., Schlensak, C., & Avci‐Adali, M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114007 · Cited by 41 · see citing works

Pulmonary surfactant as a versatile biomaterial to fight COVID-19

Herman, L., Smedt, S. C. D., & Raemdonck, K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.023 · Cited by 41 · see citing works

Are inhaled mRNA vaccines safe and effective? A review of preclinical studies

Jansen, E. M., Frijlink, H. W., Hinrichs, W. L. J., & Ruigrok, M. J. R. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2131767 · Cited by 37 · see citing works

Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects

Xu, Y., Thakur, A., Zhang, Y., & Foged, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020177 · Cited by 38 · see citing works

Development of a Spray-Dried Formulation of Peptide-DNA Nanoparticles into a Dry Powder for Pulmonary Delivery Using Factorial Design

Munir, M., Kett, V. L., Dunne, N., & McCarthy, H. O. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03256-4 · Cited by 37 · see citing works

Emerging trends in pulmonary delivery of biopharmaceuticals

Kunde, S. S., Ghosh, R., & Wairkar, S. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.02.003 · Cited by 35 · see citing works

Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials

Karimi-Sani, I., Molavi, Z., Naderi, S., Mirmajidi, S. H., Zare, I., Naeimzadeh, Y., Mansouri, A., Tajbakhsh, A., Savardashtaki, A., & Sahebkar, A. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02882-x · Cited by 38 · see citing works

Engineering Lipid Nanoparticles for mRNA Immunotherapy

Zwolsman, R. C., Darwish, Y. B., Kluza, E., & van der Meel, R. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70007 · Cited by 35 · see citing works

Advances and prospects of mRNA vaccines in cancer immunotherapy

Liu, Y., Yan, Q., Zeng, Z., Fan, C., & Xiong, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189068 · Cited by 33 · see citing works

Nuclease activity: an exploitable biomarker in bacterial infections

González, J. G., & Hernández, F. J. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2049249 · Cited by 34 · see citing works

mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends

Gao, Y., Yang, L., Li, Z., Peng, X., & Li, H. (2024) · Biomarker Research · doi:10.1186/s40364-024-00644-3 · Cited by 33 · see citing works

Inhalable mRNA vaccines for respiratory diseases: a roadmap

Roh, E. H., Fromen, C. A., & Sullivan, M. O. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.10.017 · Cited by 32 · see citing works

Development of (Inhalable) Dry Powder Formulations of AS01B-Containing Vaccines Using Thin-Film Freeze-Drying

AboulFotouh, K., Xu, H., Moon, C., Williams, R. O., & Cui, Z. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121825 · Cited by 32 · see citing works

Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4Rα Antibody for Pulmonary Delivery

Pan, H. W., Seow, H. C., Lo, J. C. K., Guo, J., Zhu, L., Leung, S. W. S., Zhang, C., & Lam, J. K. W. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03331-w · Cited by 35 · see citing works

Novel Vectors and Administrations for mRNA Delivery

Bai, C., Wang, C., & Lu, Y. (2023) · Small · doi:10.1002/smll.202303713 · Cited by 32 · see citing works

PEGylated pH-responsive peptide-mRNA nano self-assemblies enhance the pulmonary delivery efficiency and safety of aerosolized mRNA

Xu, Y., Zheng, Y., Ding, X., Wang, C., Hua, B., Hong, S., Huang, X., Lin, J., Zhang, P., & Chen, W. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2219870 · Cited by 31 · see citing works

Spray drying: Inhalable powders for pulmonary gene therapy

Munir, M., Jena, L., Kett, V. L., Dunne, N., & McCarthy, H. O. (2021) · Biomaterials Advances · doi:10.1016/j.msec.2021.112601 · Cited by 32 · see citing works

Path towards mRNA delivery for cancer immunotherapy from bench to bedside

Chen, W., Zhu, Y., He, J., & Sun, X. (2023) · Theranostics · doi:10.7150/thno.89247 · Cited by 31 · see citing works

Inhalable Dry Powders for Lung mRNA Delivery

Gordon, A. G. R., Li, B., Witten, J. J., Nguyen, H. Q., & Anderson, D. G. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400509 · Cited by 34 · see citing works

Long-acting inhaled medicines: Present and future

Zhang, C., D’Angelo, D., Buttini, F., & Yang, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115146 · Cited by 27 · see citing works

Recent Progress in Nucleic Acid Pulmonary Delivery toward Overcoming Physiological Barriers and Improving Transfection Efficiency

Wang, Q., Bu, C., Dai, Q., Chen, J., Zhang, R., Zheng, X., Ren, H., Xin, X., & Li, X. (2024) · Advanced Science · doi:10.1002/advs.202309748 · Cited by 27 · see citing works

Strategies to deliver RNA by nanoparticles for therapeutic potential

Cox, A., Lim, S. A., & Chung, E. J. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100991 · Cited by 27 · see citing works

Application of mRNA Technology in Cancer Therapeutics

Eralp, Y. (2022) · Vaccines · doi:10.3390/vaccines10081262 · Cited by 27 · see citing works

Imaging drug delivery to the lungs: Methods and applications in oncology

Man, F., Tang, J., Swedrowska, M., Forbes, B., & de Rosales, R. T. M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114641 · Cited by 26 · see citing works

Novel approach for real-time monitoring of carrier-based DPIs delivery process via pulmonary route based on modular modified Sympatec HELOS

Zhang, X., Cui, Y., Liang, R., Wang, G., Xiao, Y., Zhao, Z., Huang, Z., Huang, Y., Geng, J., Pan, X., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.013 · Cited by 25 · see citing works

Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases

Lü, Y., Tang, L., Zhang, M., & Liu, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.896958 · Cited by 27 · see citing works

Biocompatible biodegradable polymeric nanocarriers in dry powder inhalers (DPIs) for pulmonary inhalation delivery

Encinas-Basurto, D., Eedara, B. B., & Mansour, H. M. (2024) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-024-00671-0 · Cited by 24 · see citing works

Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach

Goyal, F., Chattopadhyay, A., Navik, U., Jain, A., Reddy, P. H., Bhatti, G. K., & Bhatti, J. S. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300255 · Cited by 24 · see citing works

Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis

Shao, Z., Chow, M. Y. T., Chow, S. F., & Lam, J. K. W. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03488-y · Cited by 22 · see citing works

Intratracheal Administration of Dry Powder Formulation in Mice

Qiu, Y., Liao, Q., Chow, M. Y. T., & Lam, J. K. W. (2020) · Journal of Visualized Experiments · doi:10.3791/61469 · Cited by 21 · see citing works

Nonviral targeted mRNA delivery: principles, progresses, and challenges

He, X., Li, G., Huang, L., Shi, H., Zhong, S., Zhao, S., Jiao, X., Xin, J., Yin, X., Liu, S., et al. (2025) · MedComm · doi:10.1002/mco2.70035 · Cited by 20 · see citing works

Soybean Oil‐Derived Lipids for Efficient mRNA Delivery

Tang, Z., Yu, F., Hsu, J. C., Shi, J., & Cai, W. (2023) · Advanced Materials · doi:10.1002/adma.202302901 · Cited by 20 · see citing works

A real-time and modular approach for quick detection and mechanism exploration of DPIs with different carrier particle sizes

Cui, Y., Huang, Y., Zhang, X., Lu, X.-Y., Xue, J., Wang, G., Hu, P., Xiao, Y., Zhao, Z., Pan, X., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.011 · Cited by 19 · see citing works

Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation

Seow, H. C., Cai, J., Pan, H. W., Luo, C., Wen, K., Situ, J., Wang, K., Cao, H., Leung, S. W. S., Yuan, S., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.029 · Cited by 19 · see citing works

Non-viral mRNA delivery to the lungs

Healy, L., Seto, B. Y., Cui, H., & Li, B. (2025) · Biomaterials Science · doi:10.1039/d5bm00322a · Cited by 18 · see citing works

Nucleic acid delivery by lipid nanoparticles for organ targeting

Guo, J., Gu, M., Chen, Y., Xiong, T., Zhang, Y., Chen, S., Li, M., Chen, X., & Peng, X. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.110849 · Cited by 18 · see citing works

Inhaled non-viral delivery systems for RNA therapeutics

Huang, C., Li, H., Duan, X., Zhang, P., Qi, S., Du, J., Song, X., Tong, A., & Yu, G. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.033 · Cited by 21 · see citing works

Optimizations of In Vitro Mucus and Cell Culture Models to Better Predict In Vivo Gene Transfer in Pathological Lung Respiratory Airways: Cystic Fibrosis as an Example

Ghanem, R., Laurent, V., Roquefort, P., Haute, T., Ramel, S., Gall, T. L., Aubry, T., & Montier, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010047 · Cited by 17 · see citing works

Optimization of PEGylated KL4 Peptide for siRNA Delivery with Improved Pulmonary Tolerance

Qiu, Y., Clarke, M., Wan, L. T. L., Lo, J. C. K., Mason, A. J., & Lam, J. K. W. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c01242 · Cited by 17 · see citing works

Peptidyl Virus‐Like Nanovesicles as Reconfigurable “Trojan Horse” for Targeted siRNA Delivery and Synergistic Inhibition of Cancer Cells

Wang, Z., Hao, D., Wang, Y., Zhao, J., Zhang, J., Rong, X., Zhang, J., Min, J., Qi, W. D., Su, R., et al. (2022) · Small · doi:10.1002/smll.202204959 · Cited by 17 · see citing works

Co-delivery of PD-L1- and EGFR-targeting siRNAs by synthetic PEG12-KL4 peptide to the lungs as potential strategy against non-small cell lung cancer

Man, R. C. H., Qiu, Y., Leung, S. W. S., Fruhwirth, G. O., & Lam, J. K. W. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114177 · Cited by 17 · see citing works

Quaternization drives spleen-to-lung tropism conversion for mRNA-loaded lipid-like nanoassemblies

Huang, Y., Wu, J., Li, S., Liu, Z., Li, Z., Zhou, B., & Li, B. (2024) · Theranostics · doi:10.7150/thno.90071 · Cited by 16 · see citing works

Understanding Mucosal Physiology and Rationale of Formulation Design for Improved Mucosal Immunity

Biswas, M., Nurunnabi, M., & Khatun, Z. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00395 · Cited by 16 · see citing works

Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles to cystic fibrosis lung epithelia

Soto, M. R., Lewis, M. M., Leal, J., Pan, Y., Mohanty, R. P., Veyssi, A., Maier, E. Y., Heiser, B. J., & Ghosh, D. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102375 · Cited by 19 · see citing works

PEGylated pH-responsive peptide-mRNA nano self-assemblies enhance the pulmonary delivery efficiency and safety of aerosolized mRNA

Xu, Y., Zheng, Y., Ding, X., Wang, C., Hua, B., Hong, S., Huang, X., Lin, J., Zhang, P., & Chen, W. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2219870 · Cited by 31 · see citing works

Inhalable Dry Powders for Lung mRNA Delivery

Gordon, A. G. R., Li, B., Witten, J. J., Nguyen, H. Q., & Anderson, D. G. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400509 · Cited by 34 · see citing works

Inhaled dry powders of mRNA polyplexes prepared by thin-film freeze-drying

Giri, B. R., Jung, Y., Moon, C., Pramodkumar, E. K., Jeong, H., Southard, B., Hwang, J., Patel, C. J., Peck, H. E., Owens, D. E., et al. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127319

Lipid nanoparticles for local delivery of mRNA to the respiratory tract: Effect of PEG-lipid content and administration route

Ongun, M., Lokras, A. G., Baghel, S. S., Shi, Z., Schmidt, S., Franzyk, H., Rades, T., Sebastiani, F., Thakur, A., & Foged, C. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114266 · Cited by 63 · see citing works

Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination

Suberi, A., Grun, M. K., Mao, T., Israelow, B., Reschke, M., Grundler, J., Akhtar, L., Lee, T., Shin, K., Piotrowski-Daspit, A. S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq0603 · Cited by 184 · see citing works